V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008963 | 10005149 | 1.77 | null | Palliative (P) | 2018-06-08 | 2018-11-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 10527906 | IRINOTECAN |
| 10008964 | 10005151 | null | 84.2 | Palliative (P) | 2016-11-22 | 2016-11-22 | Brentuximab | 02 | N | 10529167 | CISPLATIN + RT |
| 10008965 | 10007579 | null | 79.3 | Palliative (P) | 2019-08-11 | 2019-09-13 | CAV | 02 | Y | 10531615 | TRIPLE INTRATHECAL |
| 10008966 | 10005176 | 0 | null | Palliative (P) | null | 2019-03-04 | Capecitabine + Cisplatin | null | null | 10534514 | LOMUSTINE |
| 10008967 | 10005185 | 1.82 | null | Not known (9) | 2017-11-25 | 2017-12-29 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | null | 10535409 | IPILIMUMAB + NIVOLUMAB |
| 10008968 | 10005187 | null | 66 | Palliative (P) | 2016-09-01 | 2016-09-08 | Irinotecan | N | N | 10535624 | ERLOTINIB |
| 10008969 | 10005192 | 1.63 | 53.9 | Palliative (P) | 2019-03-07 | 2019-03-07 | GALLIUM TRIAL | 2 | N | 10536379 | BORTEZOMIB |
| 10008970 | 10005199 | 1.7 | 98.3 | Palliative (P) | 2019-01-09 | 2019-01-21 | Melphalan IV High dose | 2 | N | 10536766 | BORTEZOMIB |
| 10008971 | 10005200 | 1.76 | 106 | Palliative (P) | 2015-03-11 | 2015-11-01 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10536813 | ENZALUTAMIDE |
| 10008972 | 10005210 | 1.83 | 85.5 | Palliative (P) | 2013-05-25 | 2014-01-03 | STAMPEDE TRIAL | Y | N | 10537747 | CISPLATIN + VINORELBINE |
| 10008973 | 10007601 | 1.71 | 95.1 | Palliative (P) | 2017-04-14 | 2017-05-20 | CHOP R + METHOTREXATE | N | N | 10538200 | CVD |
| 10008974 | 10005216 | null | 65 | Palliative (P) | null | 2017-10-27 | CYCLOPHOSPHAMIDE | N | N | 10538869 | ENZALUTAMIDE |
| 10008975 | 10005221 | 1.7 | 56.6 | Palliative (P) | 2018-04-24 | 2018-05-10 | Trifluridine + Tipiracil | N | N | 10539671 | CETUXIMAB + IRINOTECAN + MDG |
| 10008976 | 10005229 | 1.8 | 73 | Adjuvant (A) | 2015-12-31 | 2016-01-30 | Mitomycin Intravesical | 2 | N | 10541003 | ECX |
| 10008977 | 10005232 | 1.62 | 57 | null | 2019-02-21 | 2019-03-20 | FEC | 2 | N | 10541130 | PERTUZUMAB + TRASTUZUMAB |
| 10008978 | 10007608 | 1.7 | 82.4 | Palliative (P) | 2018-01-12 | 2018-01-13 | Paclitaxel albumin (Abraxane) 21day | N | N | 10541907 | CISPLATIN + VINORELBINE + RT |
| 10008979 | 10005239 | 1.63 | 62 | Palliative (P) | 2018-05-18 | 2018-07-07 | Cyclophosphamide High Dose | N | N | 10542182 | IPILIMUMAB + NIVOLUMAB |
| 10008980 | 10005248 | 1.67 | 82.8 | Disease modification (D) | 2018-03-05 | 2018-03-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 10543189 | STAMPEDE TRIAL |
| 10008981 | 10005253 | 1.77 | 93 | Palliative (P) | 2019-12-02 | 2019-12-15 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 10543801 | RALTITREXED |
| 10008982 | 10005255 | 1.75 | 63.4 | null | 2017-10-18 | 2018-11-08 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 10543951 | ENZALUTAMIDE |
| 10008983 | 10005256 | 1.79 | null | Palliative (P) | 2018-03-26 | 2018-03-27 | Doxorubin 50mg/m2 | 2 | N | 10544006 | OFATUMUMAB |
| 10008984 | 10005259 | 1.66 | null | Palliative (P) | 2014-10-22 | 2014-11-22 | Methotrexate intrathecal | 02 | null | 10544223 | FLAIR TRIAL |
| 10008985 | 10005262 | 1.75 | 77.9 | Palliative (P) | null | 2016-01-21 | CHLVPP | 2 | N | 10544323 | CAPECITABINE + GEMCITABINE |
| 10008986 | 10005265 | 1.62 | 98 | Palliative (P) | 2019-04-01 | 2019-04-02 | Cisplatin + Pemetrexed | N | N | 10544570 | METHOTREXATE INTRATHECAL |
| 10008987 | 10005268 | 0 | null | Disease modification (D) | 2016-11-21 | 2016-11-21 | Cyclophosphamide Weekly PO | N | N | 10544598 | ECX |
| 10008988 | 10005279 | 1.8 | 73.6 | Palliative (P) | 2019-03-04 | 2019-03-11 | Cetuximab 7 day (Cycle 1) | 2 | N | 10545602 | BEXAROTENE |
| 10008989 | 10005284 | 1.68 | 93.7 | Palliative (P) | 2016-01-05 | 2016-01-06 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 10545700 | BEVACIZUMAB + CAPECITABINE |
| 10008990 | 10005288 | 1.65 | 87.4 | Curative (C) | 2017-09-24 | 2017-10-19 | DABRAFENIB + TRAMETINIB | 2 | N | 10545974 | PANITUMUMAB |
| 10008991 | 10005292 | 1.77 | 62.8 | Palliative (P) | 2014-12-10 | 2015-01-16 | VISMODEGIB | 2 | N | 10546378 | IPILIMUMAB |
| 10008992 | 10005294 | 0 | 79.4 | Curative (C) | 2018-12-07 | 2019-02-09 | Trifluridine + Tipiracil | 02 | N | 10546510 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 10008993 | 10005297 | 1.75 | 76.9 | Palliative (P) | 2018-05-02 | 2018-06-20 | Trifluridine + Tipiracil | N | N | 10546566 | CARBOPLATIN + LIPOSOMAL DOX |
| 10008994 | 10005301 | null | 60 | Palliative (P) | 2014-06-24 | 2014-07-01 | Cisplatin + Vinorelbine (PO) | N | null | 10546808 | CAPECITABINE + IRINOTECAN |
| 10008995 | 10007641 | 1.81 | 68.9 | Palliative (P) | 2019-04-23 | 2019-04-29 | NIVOLUMAB | null | N | 10548704 | ENZALUTAMIDE |
| 10008996 | 10005318 | 1.73 | 70.3 | Palliative (P) | 2017-09-18 | 2017-09-19 | RCEOP | N | Y | 10548978 | EOX |
| 10008997 | 10005327 | 1.72 | 66 | null | 2018-07-25 | 2018-10-24 | Cyclophosphamide Weekly PO | 2 | N | 10549872 | FEC |
| 10008998 | 10005329 | null | 105 | Palliative (P) | 2018-08-30 | 2018-08-30 | CARBOPLATIN + RT | 2 | N | 10550104 | ESHAP |
| 10008999 | 10005331 | 1.8 | 82.6 | Palliative (P) | 2019-01-01 | 2019-01-01 | Cisplatin + Pemetrexed | 02 | N | 10550149 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 10009000 | 10005343 | 1.71 | 53.45 | Curative (C) | 2017-04-04 | 2017-05-22 | Lomustine | N | null | 10551778 | BRENTUXIMAB |
| 10009001 | 10007656 | 1.5 | 61 | Palliative (P) | 2018-04-09 | 2018-04-11 | CRIZOTINIB | N | N | 10552352 | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 10009002 | 10007662 | 1.91 | null | Palliative (P) | null | 2019-11-15 | ECX | N | N | 10554850 | GEMCITABINE + PACLITAXEL |
| 10009003 | 10007666 | 1.57 | 64.6 | Palliative (P) | 2019-02-12 | 2019-02-15 | Trifluridine + Tipiracil | 02 | N | 10556888 | METHOTREXATE INTRATHECAL |
| 10009004 | 10009038 | 1.58 | 55.7 | Palliative (P) | 2017-11-08 | 2018-05-15 | DABRAFENIB + TRAMETINIB | N | N | 10557484 | CETUXIMAB |
| 10009005 | 10005368 | 1.76 | 71.7 | Palliative (P) | 2019-07-06 | 2019-07-26 | OXALIPLATIN | N | N | 10557618 | BORTEZOMIB + THALIDOMIDE |
| 10009006 | 10005371 | 1.88 | 77.9 | Palliative (P) | 2019-06-25 | 2019-08-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 10558076 | CYTARABINE |
| 10009007 | 10007670 | 1.84 | 70.8 | Adjuvant (A) | null | 2016-06-14 | Cisplatin + Radiotherapy | N | N | 10558140 | NILOTINIB |
| 10009008 | 10005376 | 1.77 | 98.3 | null | 2018-07-01 | 2018-07-02 | Cisplatin | null | N | 10558553 | CRIZOTINIB |
| 10009009 | 10007674 | 1.66 | 76.2 | Disease modification (D) | 2018-11-30 | 2018-12-09 | GEM-P | 2 | N | 10558965 | MUK7 TRIAL |
| 10009010 | 10005385 | 1.74 | 79 | null | 2017-01-30 | 2017-12-05 | CARBOPLATIN + RT | 2 | N | 10559587 | CAPECITABINE + CISPLATIN + RT |
| 10009011 | 10005386 | 1.71 | 90 | Curative (C) | 2017-07-27 | 2017-08-29 | DOCETAXEL + TRASTUZUMAB | N | N | 10559809 | CAPECITABINE + CARBOPLATIN + RT |
| 10009012 | 10005391 | null | 116.3 | Disease modification (D) | null | 2019-09-28 | CARDAMON trial | 02 | N | 10561026 | EOF |